tenofovir disoproxil maleate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TENOFOVIR DISOPROXIL VIATRIS tenofovir disoproxil maleate 300 mg film coated tablet bottle AUST R: 261093Active ingredients:
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
28 Jul 2026
to
30 Sep 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply. Alternative brands are available.
|
TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ Viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle AUST R: 280721Active ingredients:
efavirenz
emtricitabine
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
23 Jun 2026
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options. An overseas-registered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group, can be contacted for details on supply on 1300 077 674.
|